{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["6(4)"],"submitter":["Nakano D"],"pubmed_abstract":["(a) Summary for SGLT2i-induced alterations in 48 chemokines/cytokines in Hep3B and Huh7 cells. (b) SGLT2i-induced changes in the medium CXCL1 level (each <i>n</i> = 4). (c) SGLT2i-induced changes in the medium CXCL8 level (each <i>n</i> = 4). (d) SGLT2i-induced changes in the medium CXCL10 level (each <i>n</i> = 4), (e) SGLT2i-induced changes in the medium M-CSF level (each <i>n</i> = 4). The SGLT2i-induced significant changes in chemokines/cytokines are expressed as the percentage of control (the mean value of the control was set as 100%). CXCL, C-X-C motif chemokine ligand; G-CSF, granulocyte colony-stimulating factor; IL, interleukin; LIF, leukemia inhibitory factor; M-CSF, macrophage colony-stimulating factor; MIP-1α, macrophage inflammatory protein-1α; SDF-1α, stromal-cell-derived fac"],"journal":["JGH open : an open access journal of gastroenterology and hepatology"],"pagination":["270-273"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9021706"],"repository":["biostudies-literature"],"pubmed_title":["Effects of SGLT2 inhibitor on tumor-releasing chemokines/cytokines in Hep3B and Huh7 cells."],"pmcid":["PMC9021706"],"pubmed_authors":["Yoshio S","Koga H","Torimura T","Tsutsumi T","Nakano D","Kawaguchi T","Hayakawa M"],"additional_accession":[]},"is_claimable":false,"name":"Effects of SGLT2 inhibitor on tumor-releasing chemokines/cytokines in Hep3B and Huh7 cells.","description":"(a) Summary for SGLT2i-induced alterations in 48 chemokines/cytokines in Hep3B and Huh7 cells. (b) SGLT2i-induced changes in the medium CXCL1 level (each <i>n</i> = 4). (c) SGLT2i-induced changes in the medium CXCL8 level (each <i>n</i> = 4). (d) SGLT2i-induced changes in the medium CXCL10 level (each <i>n</i> = 4), (e) SGLT2i-induced changes in the medium M-CSF level (each <i>n</i> = 4). The SGLT2i-induced significant changes in chemokines/cytokines are expressed as the percentage of control (the mean value of the control was set as 100%). CXCL, C-X-C motif chemokine ligand; G-CSF, granulocyte colony-stimulating factor; IL, interleukin; LIF, leukemia inhibitory factor; M-CSF, macrophage colony-stimulating factor; MIP-1α, macrophage inflammatory protein-1α; SDF-1α, stromal-cell-derived fac","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Apr","modification":"2025-04-04T19:09:46.998Z","creation":"2025-04-04T19:09:46.998Z"},"accession":"S-EPMC9021706","cross_references":{"pubmed":["35475201"],"doi":["10.1002/jgh3.12730"]}}